Back to search

Article

Novel plasma exosome biomarkers for prostate cancer progression in co-morbid metabolic disease

2022-02-04

Abstract excerpt

Comorbid Type 2 diabetes (T2D), a metabolic complication of obesity, associates with worse cancer outcomes for prostate, breast, head and neck, colorectal and several other solid tumors. However, the molecular mechanisms remain poorly understood. Emerging evidence shows that exosomes carry miRNAs in blood that encode the metabolic status of originating tissues and deliver their cargo to target tissues to modulate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7dd69308-0b29-5059-b4a5-19b97d3366e7
DOI
10.1101/2022.02.01.478722
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel plasma exosome biomarkers for prostate cancer progression in co-morbid metabolic diseaseDOI 10.1101/2022.02.01.478722
Select a neighboring publication to make it the new centre.